Company Overview of Relypsa, Inc.
Relypsa, Inc., a pharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States. The company’s principal product candidate includes Patiromer, a non-absorbed potassium binder that completed Phase 3 clinical trial for the treatment of hyperkalemia. It also offers RLY6002, a pre-clinical product candidate that evaluates as an adjunct to diet and exercise to enhance glycemic control in adults with type 2 diabetes mellitus. The company was founded in 2007 and is headquartered in Redwood City, California.
700 Saginaw Drive
Redwood City, CA 94063
Founded in 2007
Key Executives for Relypsa, Inc.
Relypsa, Inc. Key Developments
Similar Private Companies By Industry
|Intellikine, Inc.||United States|
|SinoFresh Healthcare Inc.||United States|
|Capricorn Pharma, Inc.||United States|
|Vemas Herb & Health||United States|
|Knoll Pharmaceutical Company||United States|
Recent Private Companies Transactions
May 30, 2014
To contact Relypsa, Inc., please visit www.relypsa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.